PharmaPendium
"PharmaPendium" is a word mark owned by Elsevier Limited, filed at the CIPO on March 2, 2010. It is registered and covers classes 9, 38, 41 and 42.
- Status
- Registered
- Since February 25, 2013
- Filed
- March 2, 2010
- Registered
- February 25, 2013
- Expires
- February 25, 2028
- Application no.
- 1471441
- Registration no.
- TMA844438
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 4 classes
Who owns PharmaPendium
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Elsevier Limited
United Kingdom
Representative
Gowling WLG (Canada) LLP
Gowling WLG (Canada) LLP
What the mark covers
The products and services PharmaPendium is filed for, grouped by Nice class.
Computer programs and software used for searching data in the fields of drug discovery and development; periodical publications, namely, magazines, journals, newspapers, newsletters, catalogs and brochures featuring topics in the fields of drug discovery and development in electronic downloadable format or recorded on computer media.
Providing access to computer databases in the fields of drug discovery and development; publishing of online electronic publications; publishing of magazines and news magazines by electronic means; provision of publications, namely, magazines, journals, reviews and newsletters on the Internet with navigation function; arranging and conducting training workshops, organization and management of demonstrations and exhibitions for educational purposes, and organizing colloquiums, conventions, seminars, workshops and training courses, all of the foregoing in the fields of drug discovery and development; educational and training services, namely, conducting classes, seminars, conferences, workshops, providing information in the field of educational demonstrations and exhibitions, colloquiums, conventions, seminars, workshops and educational events, all of the foregoing in the fields of drug discovery and development; providing information, assistance and consultancy for participants, visitors and exhibitors of educational exhibitions and colloquiums in the fields of drug discovery and development, provided in person and electronically via a web site; scientific research in the field of drug discovery and development; industrial research in the field of drug discovery and development; computer programming services; rental of computer software; consultation and providing information in the field of drug discovery and development.
Providing access to computer databases in the fields of drug discovery and development; publishing of online electronic publications; publishing of magazines and news magazines by electronic means; provision of publications, namely, magazines, journals, reviews and newsletters on the Internet with navigation function; arranging and conducting training workshops, organization and management of demonstrations and exhibitions for educational purposes, and organizing colloquiums, conventions, seminars, workshops and training courses, all of the foregoing in the fields of drug discovery and development; educational and training services, namely, conducting classes, seminars, conferences, workshops, providing information in the field of educational demonstrations and exhibitions, colloquiums, conventions, seminars, workshops and educational events, all of the foregoing in the fields of drug discovery and development; providing information, assistance and consultancy for participants, visitors and exhibitors of educational exhibitions and colloquiums in the fields of drug discovery and development, provided in person and electronically via a web site; scientific research in the field of drug discovery and development; industrial research in the field of drug discovery and development; computer programming services; rental of computer software; consultation and providing information in the field of drug discovery and development.
Providing access to computer databases in the fields of drug discovery and development; publishing of online electronic publications; publishing of magazines and news magazines by electronic means; provision of publications, namely, magazines, journals, reviews and newsletters on the Internet with navigation function; arranging and conducting training workshops, organization and management of demonstrations and exhibitions for educational purposes, and organizing colloquiums, conventions, seminars, workshops and training courses, all of the foregoing in the fields of drug discovery and development; educational and training services, namely, conducting classes, seminars, conferences, workshops, providing information in the field of educational demonstrations and exhibitions, colloquiums, conventions, seminars, workshops and educational events, all of the foregoing in the fields of drug discovery and development; providing information, assistance and consultancy for participants, visitors and exhibitors of educational exhibitions and colloquiums in the fields of drug discovery and development, provided in person and electronically via a web site; scientific research in the field of drug discovery and development; industrial research in the field of drug discovery and development; computer programming services; rental of computer software; consultation and providing information in the field of drug discovery and development.
What has happened so far
Steps recorded by the CIPO, newest first.
- Agent Changed; From/De: 10425 To/A: 8390
- Change of Title Registered; Assignment / Voir Preuve au dossier/See evidence on File No. 1640234
- FROM: ELSEVIER LIFE SCIENCES IP LIMITED; TO: ELSEVIER LIMITED; Nunc Pro Tunc July 2nd, 2018; Voir Preuve au dossier/See evidence on File No. 1640234
- To correct owner's postal code in the address by adding 'G', now reads: OX5 1GB; Voir Preuve au dossier/See evidence on File No. 1640234
- Amendment to Registration; Section 41(1)(a) - Owner Information / Voir Preuve au dossier/See evidence on File No. 1640234
- Change of Title Registered; Assignment / Voir Preuve au dossier/See evidence on File No. 1640234
- Rep for Service Changed; From: 6489 To: 10425 / Voir Preuve au dossier/See evidence on File No. 1640234
- FROM: RELX Intellectual Properties SA; TO: ELSEVIER LIFE SCIENCES IP LIMITED; Nunc pro tunc September 29, 2017; Voir Preuve au dossier/See evidence on File No. 1640234
- Amendment to Registration; Name / Voir Preuve au dossier/See evidence on File No. 575141
- FROM: REED ELSEVIER PROPERTIES SA; TO: RELX Intellectual Properties SA; Voir Preuve au dossier/See evidence on File No. 575141
10 earlier steps on the official record.
About PharmaPendium
Who owns the trademark "PharmaPendium"?
The CIPO trademark "PharmaPendium" (application 1471441) is owned by Elsevier Limited.
What is the status of "PharmaPendium"?
Its status at the CIPO is: registered.
When was "PharmaPendium" registered?
It was registered on February 25, 2013 and is due to expire on February 25, 2028.
Get this data via the API
Everything on this page comes from the Signa API. Pull PharmaPendium and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019dec4e-05d4-71e7-9a89-b641fb0b0937
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019dec4e-05d4-71e7-9a89-b641fb0b0937",
"object": "trademark",
"mark_text": "PharmaPendium",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1471441",
"filing_date": "2010-03-02",
"nice_classes": [
9,
38,
41,
42
],
"owners": [
{
"name": "ELSEVIER LIMITED",
"entity_id": "ent_019eb70c-91c2-71a2-a8ef-67d66b5d9fd9"
}
]
}